UE
Uy Ear Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
3.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $12 |
10%
downside
| 3 | -53% |
0
%
| 3 Mar ‘26 3 days ago |
|
|
|
Outperform
Maintained
| $35 |
48%
upside
| 2 | -13% |
0
%
| 2 Mar ‘26 4 days ago |
|
|
|
Outperform
Upgraded
| $35 |
60%
upside
| 4 | -9% |
0
%
| 23 Feb ‘26 11 days ago |
|
|
|
Neutral
Maintained
| $175 |
37%
upside
| 1 | – |
–
| 12 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $19 |
267%
upside
| 1 | -24% |
0
%
| 2 Dec ‘25 3 months ago |
|
|
|
Outperform
Upgraded
| $10 |
124%
upside
| 1 | +4.7% |
0
%
| 19 Nov ‘25 3 months ago |
|
|
|
Outperform
Upgraded
| $26 |
66%
upside
| 4 | -26% |
0
%
| 5 Nov ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $45 |
60%
upside
| 1 | -5.6% |
0
%
| 27 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $56 |
85%
upside
| 2 | +56% |
0
%
| 24 Sep ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $85 |
155%
upside
| 2 | +42% |
0
%
| 15 May ‘25 9 months ago |
|